| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/01/2009 | US20090004175 Methods for Optimizing Forming Vlla-Based Hemostatic Treatment |
| 01/01/2009 | US20090004174 Fusion Proteins |
| 01/01/2009 | US20090004173 Diagnosis and Treatment of Drug Resistant Leukemia |
| 01/01/2009 | US20090004172 Service for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using erp57 translocation |
| 01/01/2009 | US20090004171 Compound profiling method |
| 01/01/2009 | US20090004169 Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof |
| 01/01/2009 | US20090004168 Health Enhancement System |
| 01/01/2009 | US20090004166 Carrier For Enternal Administration |
| 01/01/2009 | US20090004163 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 01/01/2009 | US20090004162 Hecgf-1 Related Polymorphisms and Applications Thereof |
| 01/01/2009 | US20090004160 Mass Producing Method of Growth Factor Using Adipose Derived Adult Stem Cells |
| 01/01/2009 | US20090004158 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004143 Treatment of diseases caused by viral infection |
| 01/01/2009 | US20090004142 A cell therapy method for the treatment of tumors |
| 01/01/2009 | US20090004141 Broad spectrum immune and antiviral gene modulation by oral interferon |
| 01/01/2009 | US20090004140 4-substituted pyrrolidine as anti-infectives |
| 01/01/2009 | US20090004139 Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
| 01/01/2009 | US20090004138 Bicyclic Nucleosides and Nucleotides as Therapeutic Agents |
| 01/01/2009 | US20090004137 Uridine Derivatives as Antiviral Drugs Against a Flaviviridae, Especially Hcv |
| 01/01/2009 | US20090004136 administering to a cancer patients, heterocyclic trialkyl ammonium-compounds such as [3-(3,4-dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-2-hydroxypropyl]trimethylammonium chloride, to normalize blood cell and platelet counts and to reduce side effects of radiotherapy and chemotherapy |
| 01/01/2009 | US20090004135 Modified fluorinated nucleoside analogues |
| 01/01/2009 | US20090004134 Kit for treating a health condition by inducing translocation of an erp57 protein to a cellular membrane |
| 01/01/2009 | US20090004104 Methods and Compositions for Delivering Active Agents with Enhanced Pharmacological Properties |
| 01/01/2009 | US20090004101 Method and Means for Enhanced Pulmonary Drug Delivery |
| 12/31/2008 | WO2009003164A1 Compositions comprising indoleamine 2,3- dioxygenase-2 and coenzyme q inhibitors and methods of use thereof |
| 12/31/2008 | WO2009003147A1 Methods and compositions for the treatment of neurological disorders |
| 12/31/2008 | WO2009003125A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 12/31/2008 | WO2009003096A2 Il-17 mutein proteins, antibodies, compositions, methods and uses |
| 12/31/2008 | WO2009003037A1 Peptide tyrosinase inhibitors and uses thereof |
| 12/31/2008 | WO2009003034A1 Oligopeptide tyrosinase inhibitors and uses thereof |
| 12/31/2008 | WO2009002947A2 Compounds and peptides that bind the trail receptor |
| 12/31/2008 | WO2009002811A2 Therapeutic platelet compositions and methods |
| 12/31/2008 | WO2009002768A2 Liquid bandage |
| 12/31/2008 | WO2009002669A2 Small peptides specifically bind to colorectal cancers |
| 12/31/2008 | WO2009002529A2 Labeled inhibitors of prostate specific membrane antigen (psma), biological evaluation, and use as imaging agents |
| 12/31/2008 | WO2009002516A1 Influenza inhibiting compositions and methods |
| 12/31/2008 | WO2009002481A1 Lyophilized anti-fungal composition |
| 12/31/2008 | WO2009002456A2 Methods and compositions relating to progenitor cells |
| 12/31/2008 | WO2009002437A2 Neurotoxin theraphy for postprandial hyperglycemia |
| 12/31/2008 | WO2009002264A1 Cell penetrating peptides for treatment of protozoa mediated diseases such as malaria |
| 12/31/2008 | WO2009002203A1 Polyfunctional fullerene c60 aminoacid derivatives |
| 12/31/2008 | WO2009001928A1 Peptide having hypotensive activity |
| 12/31/2008 | WO2009001884A1 Oxidized glutathione tablet |
| 12/31/2008 | WO2009001743A1 Novel adamts-13 mutant |
| 12/31/2008 | WO2009001555A1 Expression controller of type i interferon |
| 12/31/2008 | WO2009001392A1 Gene codifying for ambra 1 protein which regulates autophagv and the development of the central nervous system |
| 12/31/2008 | WO2009001315A2 Use of a class of genes encoding lysophospholipid acyl transferases for application in agriculture, biotechnology, and medicine |
| 12/31/2008 | WO2009001260A2 Cosmetic use of apolipoprotein d type proteins |
| 12/31/2008 | WO2009001058A1 Modified chondroitinase polypeptides |
| 12/31/2008 | WO2009001032A1 Modulation of inflammation |
| 12/31/2008 | WO2009000971A2 Peptide gacfsiahecga for targeting mtl-mmp |
| 12/31/2008 | WO2009000929A2 Composition and method for treatment of autoimmune disease |
| 12/31/2008 | WO2009000899A1 A novel strain of bifidobacterium and active peptides against rotavirus infections |
| 12/31/2008 | WO2009000763A1 Process for purifying apyrogenic and virus-inactivated human hemoglobin |
| 12/31/2008 | WO2009000433A1 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| 12/31/2008 | WO2009000297A1 Tpp ii inhibitors for use in combination with chemotherapy for the treatment of cancer |
| 12/31/2008 | WO2009000296A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | WO2009000137A1 A inhibiting agent for inhibition of angiogenesis, a method for preparing the agnet, a method for modifying the agent and its use for manufacturing a medicament for treating tumor |
| 12/31/2008 | WO2009000089A1 Immunomodulatory compositions and methods for treating disease with modified host defense peptides |
| 12/31/2008 | WO2009000077A1 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 12/31/2008 | WO2008141012A3 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof |
| 12/31/2008 | WO2008140782A3 Compounds for enzyme inhibition |
| 12/31/2008 | WO2008138131B1 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 12/31/2008 | WO2008138131A4 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 12/31/2008 | WO2008137838A3 Interferon alpha-induced pharmacodynamic markers |
| 12/31/2008 | WO2008137471A3 Modified interferon beta polypeptides and their uses |
| 12/31/2008 | WO2008136888A3 Second generation low oxygen affinity pegylated hemoglobins as oxygen-carrying plasma expanders |
| 12/31/2008 | WO2008135419A3 Anti-il-6-agents for improving primary functioning of allogenic grafts |
| 12/31/2008 | WO2008132568A3 Fusion proteins binding to growth factors |
| 12/31/2008 | WO2008127654A3 Methods and compositions for intra-articular coagulation proteins |
| 12/31/2008 | WO2008116648A3 Novel glp-1 fusion peptides, their production and use |
| 12/31/2008 | WO2008099742A3 Ejection liquid and ejection method |
| 12/31/2008 | WO2008091632A3 A peptide composition and a method of promoting cartilage formation |
| 12/31/2008 | WO2008086025A3 Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity |
| 12/31/2008 | WO2008084478A8 Anti-bacterial peptides and methods of treating diseases using same |
| 12/31/2008 | WO2008079973A9 Egfr binding peptides and uses thereof |
| 12/31/2008 | WO2008079973A8 Egfr binding peptides and uses thereof |
| 12/31/2008 | WO2008073294A3 Inhibition of angiogenesis and tumor growth by inhibitors of beta ii or delta protein kinase c |
| 12/31/2008 | WO2008070132A3 Methods of use of trk receptor modulators |
| 12/31/2008 | WO2008060552A3 Synthetic peptide amides and dimers thereof |
| 12/31/2008 | WO2008033847A8 Modified protein polymers |
| 12/31/2008 | WO2008013955A3 Sustained release formulations for pulmonary delivery |
| 12/31/2008 | WO2007149343A3 Proteases for treatment of venomous bites |
| 12/31/2008 | WO2007140474A3 Compositions and methods for detection and modulation of t cell mediated immune responses against viral vectors utilized for gene therapy |
| 12/31/2008 | WO2007140284A3 N-terminally modified glp-1 receptor modulators |
| 12/31/2008 | WO2007105218A3 Composition and method for brain tumor therapy |
| 12/31/2008 | WO2007044026A3 Compositions comprising modified collagen and uses therefore |
| 12/31/2008 | EP2009119A1 Compositions for treating cancer using viruses |
| 12/31/2008 | EP2009117A2 Method for diagnosing pancreatic cancer |
| 12/31/2008 | EP2009104A1 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 12/31/2008 | EP2009103A1 Neurotrophic peptides |
| 12/31/2008 | EP2009025A1 Method of inhibiting osteoclast activity |
| 12/31/2008 | EP2009024A1 Glucagon-like peptide-2 analogs |
| 12/31/2008 | EP2009023A1 Novel peptides and their use for the treatment of edema |
| 12/31/2008 | EP2009019A1 P53 binding T cell receptor molecules and uses thereof |
| 12/31/2008 | EP2009018A2 T cell antigen receptor peptides |
| 12/31/2008 | EP2008664A2 Modified proteins which bind extracellular matrix components |
| 12/31/2008 | EP2008663A1 Liquid composition for external application and preparation for external application for treatment of skin ulcer |
| 12/31/2008 | EP2008649A1 Spill resistant pharmaceutical compositions |